Mexico - Delayed Quote MXN
AbbVie Inc. (ABBV.MX)
3,600.00
0.00
(0.00%)
At close: June 5 at 1:47:45 PM CST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 15 | 14 | 25 | 26 |
Avg. Estimate | 14.93B | 15.34B | 59.87B | 64.64B |
Low Estimate | 14.5B | 15.04B | 59.27B | 62.22B |
High Estimate | 15.18B | 15.71B | 60.85B | 67.18B |
Year Ago Sales | 14.46B | 14.46B | 56.33B | 59.87B |
Sales Growth (year/est) | 3.24% | 6.10% | 6.27% | 7.98% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ABBV.MX | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
Downgrade | Citigroup: Buy to Neutral | 5/14/2025 |
Maintains | Guggenheim: Buy to Buy | 4/29/2025 |
Maintains | Raymond James: Outperform to Outperform | 4/28/2025 |
Maintains | Evercore ISI Group: Outperform to Outperform | 4/28/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 4/28/2025 |
Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |